Treats hypertension. ANDA 78020, held by Mylan Pharms Inc. Hydrochlorothiazide; Valsartan.
As of Nov 16, 2026, ANDA 78020 (Valsartan And Hydrochlorothiazide), held by Mylan Pharms Inc, was first approved by FDA on Sep 21, 2012, with 6 approved supplements and 0 published complete response letters.
Valsartan and hydrochlorothiazide tablets are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes, including hydrochlorothiazide and the angiotensin II receptor blocker (ARB) class to which valsartan principally belongs. There are no controlled trials demonstrating risk reduction with valsartan and hydrochlorothiazide tablets.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 21, 2012 | Original application | Approved |
| Valsartan And Hydrochlorothiazide12.5MG;80MG · tablet;oral | Hydrochlorothiazide; Valsartan | Rx |
| Valsartan And Hydrochlorothiazide12.5MG;160MG · tablet;oral | Hydrochlorothiazide; Valsartan | Rx |
| Valsartan And Hydrochlorothiazide25MG;160MG · tablet;oral | Hydrochlorothiazide; Valsartan | Rx |
| Valsartan And Hydrochlorothiazide12.5MG;320MG · tablet;oral | Hydrochlorothiazide; Valsartan | Rx |
| Valsartan And Hydrochlorothiazide25MG;320MG · tablet;oral | Hydrochlorothiazide; Valsartan | Rx |
| Apr 11, 2024 | Supplement 15Labeling · Standard review | Approved | None posted |
| Sep 6, 2019 | Supplement 13Labeling · Standard review | Approved | None posted |
| Dec 1, 2015 | Supplement 8Labeling · Standard review | Approved | None posted |
| Jul 15, 2015 | Supplement 5Labeling · Standard review | Approved | None posted |
| Jul 15, 2015 | Supplement 7Labeling · Standard review | Approved | None posted |
| Dec 14, 2012 | Supplement 2Labeling · Standard review | Approved | None posted |
| Sep 21, 2012 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters